Literature DB >> 31307115

Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction.

Marco Onofrj1, Alberto J Espay2, Laura Bonanni1, Stefano Delli Pizzi1, Stefano L Sensi1,3.   

Abstract

Hallucinations, delusions, and functional neurological manifestations (conversion and somatic symptom disorders) of Parkinson's disease (PD) and dementia with Lewy bodies increase in frequency with disease progression, predict the onset of cognitive decline, and eventually blend with and are concealed by dementia. These symptoms share the absence of reality constraints and can be considered comparable elements of the PD-dementia with Lewy bodies psychosis. We propose that PD-dementia with Lewy bodies psychotic disorders depend on thalamic dysfunction promoting a theta burst mode and subsequent thalamocortical dysrhythmia with focal cortical coherence to theta electroencephalogram rhythms. This theta electroencephalogram activity, also called fast-theta or pre-alpha, has been shown to predict cognitive decline and fluctuations in Parkinson's disease with dementia and dementia with Lewy bodies. These electroencephalogram alterations are now considered a predictive marker for progression to dementia. The resulting thalamocortical dysrhythmia inhibits the frontal attentional network and favors the decoupling of the default mode network. As the default mode network is involved in integration of self-referential information into conscious perception, unconstrained default mode network activity, as revealed by recent imaging studies, leads to random formation of connections that link strong autobiographical correlates to trivial stimuli, thereby producing hallucinations, delusions, and functional neurological disorders. The thalamocortical dysrhythmia default mode network decoupling hypothesis provides the rationale for the design and testing of novel therapeutic pharmacological and nonpharmacological interventions in the context of PD, PD with dementia, and dementia with Lewy bodies.
© 2019 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; default mode network; functional disorders; hallucinations; somatic symptoms; thalamus

Mesh:

Year:  2019        PMID: 31307115      PMCID: PMC6707070          DOI: 10.1002/mds.27781

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  127 in total

1.  Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.

Authors:  R Manni; P Mazzarello
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

2.  Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years.

Authors:  Christopher G Goetz; Glenn T Stebbins; Bichun Ouyang
Journal:  Mov Disord       Date:  2011-07-13       Impact factor: 10.338

3.  Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.

Authors:  Makoto Uchiyama; Yoshiyuki Nishio; Kayoko Yokoi; Yoshiyuki Hosokai; Atsushi Takeda; Etsuro Mori
Journal:  Parkinsonism Relat Disord       Date:  2015-03-31       Impact factor: 4.891

4.  Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.

Authors:  E K Perry; C M Morris; J A Court; A Cheng; A F Fairbairn; I G McKeith; D Irving; A Brown; R H Perry
Journal:  Neuroscience       Date:  1995-01       Impact factor: 3.590

5.  Hospitalisation and comorbidities in Parkinson's disease: a large Australian retrospective study.

Authors:  Michal Lubomski; R Louise Rushworth; Stephen Tisch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-05-29       Impact factor: 10.154

Review 6.  Pedunculopontine nucleus: functional organization and clinical implications.

Authors:  Eduardo E Benarroch
Journal:  Neurology       Date:  2013-03-19       Impact factor: 9.910

Review 7.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

8.  Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.

Authors:  Marta Swirski; J Scott Miners; Rohan de Silva; Tammaryn Lashley; Helen Ling; Janice Holton; Tamas Revesz; Seth Love
Journal:  Alzheimers Res Ther       Date:  2014-12-01       Impact factor: 6.982

9.  Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study.

Authors:  Miho Murata; Toshinari Odawara; Kazuko Hasegawa; Sayaka Iiyama; Masatoshi Nakamura; Masaaki Tagawa; Kenji Kosaka
Journal:  Neurology       Date:  2018-01-24       Impact factor: 9.910

10.  Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study.

Authors:  M Dauwan; J I Hoff; E M Vriens; A Hillebrand; C J Stam; I E Sommer
Journal:  Neuroimage Clin       Date:  2019-03-13       Impact factor: 4.881

View more
  14 in total

1.  Evaluation of white matter microstructure in patients with Parkinson's disease using microscopic fractional anisotropy.

Authors:  Yutaka Ikenouchi; Koji Kamagata; Christina Andica; Taku Hatano; Takashi Ogawa; Haruka Takeshige-Amano; Kouhei Kamiya; Akihiko Wada; Michimasa Suzuki; Shohei Fujita; Akifumi Hagiwara; Ryusuke Irie; Masaaki Hori; Genko Oyama; Yashushi Shimo; Atsushi Umemura; Nobutaka Hattori; Shigeki Aoki
Journal:  Neuroradiology       Date:  2019-11-04       Impact factor: 2.804

2.  EEG Abnormalities During Delirium as a Prodromal Feature of Dementia with Lewy Bodies: A Case Report.

Authors:  Claudia Carrarini; Matteo Alessandro De Rosa; Dario Calisi; Anna Digiovanni; Pierpaolo Salute; Fedele Dono; Giacomo Evangelista; Stefano Consoli; Mirella Russo; Laura Ferri; Damiano D'Ardes; Maria Vittoria Mattoli; Francesco Cipollone; Marco Onofrj; Laura Bonanni
Journal:  J Alzheimers Dis Rep       Date:  2022-05-10

Review 3.  Electrophysiological biomarkers for deep brain stimulation outcomes in movement disorders: state of the art and future challenges.

Authors:  Martina Bočková; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2021-07-10       Impact factor: 3.575

4.  Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.

Authors:  Kyan Younes; Julio C Rojas; Amy Wolf; Goh M Sheng-Yang; Matteo Paoletti; Gianina Toller; Eduardo Caverzasi; Maria Luisa Mandelli; Ignacio Illán-Gala; Joel H Kramer; Yann Cobigo; Bruce L Miller; Howard J Rosen; Michael D Geschwind
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

5.  Functional and structural brain network correlates of visual hallucinations in Lewy body dementia.

Authors:  Ramtin Mehraram; Luis R Peraza; Nicholas R E Murphy; Ruth A Cromarty; Sara Graziadio; John T O'Brien; Alison Killen; Sean J Colloby; Michael Firbank; Li Su; Daniel Collerton; John Paul Taylor; Marcus Kaiser
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

Review 6.  The Pharmacology of Visual Hallucinations in Synucleinopathies.

Authors:  Mirella Russo; Claudia Carrarini; Fedele Dono; Marianna Gabriella Rispoli; Martina Di Pietro; Vincenzo Di Stefano; Laura Ferri; Laura Bonanni; Stefano Luca Sensi; Marco Onofrj
Journal:  Front Pharmacol       Date:  2019-12-09       Impact factor: 5.810

7.  Co-activation of rhythms during alpha band oscillations as an interictal biomarker of exploding head syndrome.

Authors:  Dimitris Fotis Sakellariou; Alexander David Nesbitt; Sean Higgins; Sandor Beniczky; Jan Rosenzweig; Panagis Drakatos; Nadia Gildeh; Patrick Brian Murphy; Brian Kent; Adrian John Williams; Meir Kryger; Peter J Goadsby; Guy Doron Leschziner; Ivana Rosenzweig
Journal:  Cephalalgia       Date:  2020-04-10       Impact factor: 6.292

8.  Impaired sensory evidence accumulation and network function in Lewy body dementia.

Authors:  Claire O'Callaghan; Michael Firbank; Alessandro Tomassini; Julia Schumacher; John T O'Brien; John-Paul Taylor
Journal:  Brain Commun       Date:  2021-08-02

9.  Differences in network controllability and regional gene expression underlie hallucinations in Parkinson's disease.

Authors:  Angeliki Zarkali; Peter McColgan; Mina Ryten; Regina Reynolds; Louise-Ann Leyland; Andrew J Lees; Geraint Rees; Rimona S Weil
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

10.  Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's disease.

Authors:  Angeliki Zarkali; Peter McColgan; Louise Ann Leyland; Andrew John Lees; Rimona Sharon Weil
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-09-28       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.